Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR) and Coherus Biosciences (CHRS)
The Market Doesn't Like What It Sees From Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Revenues Yet As Shares Tumble 28%
Coherus BioSciences Inc (CHRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
JonesTrading Maintains Coherus BioSciences(CHRS.US) With Buy Rating
Short Interest Surges to 21.83% as Coherus BioSciences, Inc. (CHRS) Faces Revenue Challenges
Institutional Owners May Take Dramatic Actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Recent 12% Drop Adds to One-year Losses
Ducati999 : hahaha and it dropped to 0.99